The generation of an efficient adaptive immune response against cancer typically occurs in secondary lymphoid organs (SLO), where antigens are presented to CD4+ T and CD8+ T cells by mature dendritic cells (DCs) (26, 27). The gene discussed is CD8A; the disease is cancer.